This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.
Recalls & Warnings July 06, 2022 FDA Warns Kratom Companies for Arthritis, Pain Relief Claims & More On January 30, 2022, the FDA issued warning letters to four sellers of kratom products because they were promoted to treat pain relief, opioid withdrawal, blood sugar control, anxiety, and to treat rheumatoid arthritis
Current nutrition guidance for GLP-1 therapy emphasizes smaller, more frequent meals and temporary avoidance of high-fat foods when symptoms are active
3 1/2 weeks in and down 12lbs with healthy eating, no soda and walking
Funding The study and all support for the manuscript, including the journals Rapid Service Fee, was funded by Eli Lilly and Company, Indianapolis, United States